Following the previous FDA approval of faricimab-svoa to treat some of the leading causes of vision loss, the Administration has approved a single-dose prefilled syringe of the drug which could lead to safer and more efficient administration while easing patient burden.
The findings show that those with higher plasma homocysteine concentrations experienced more sleep apnea events per hour compared with those with lower concentrations.
Pulsed field ablation may offer patients an efficacious treatment option with limited damage to surrounding tissues.
By developing the Shizuoka score, which features a new predictive model using machine learning, patients with Kawasaki disease who are non-responders to intravenous immunoglobulin were able to be accurately identified.
Researchers found that certain mutations in KLHL6 can lead to an increase in the number of B-cell receptors, resulting in poor outcomes for patients with diffuse large B-cell lymphoma.
ADI-270 is a gamma delta CAR T-cell therapy candidate targeting CD70-positive cancers.
Researchers identify significant proteins involved in the growth and survival of malignant multiple myeloma cells.
In the 2 mg bulevirtide (Gilead Sciences) group, 44% of individuals achieved HDV RNA that was undetectable compared with 70% in the 10 mg group.
Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.
Vitamin D could mitigate negative impacts on neurobehavior and weight gain caused by consumption of monosodium glutamate (MSG).
In 2 different dose groups, the majority of patients with eosinophilic esophagitis aged 1 to 11 achieved histologic remission at week 16 compared with patients treated with placebo.
The ACIP recommendations are designed to improve access to RSV vaccination, emphasizing the need to get vaccinated.
Pharmacists can play a crucial role in diabetes management by implementing standing order protocols for medication titration and serving as a bridge between patients and other health care providers.
Investigators found improvements over the placebo in metabolic dysfunction-associated steatohepatitis without worsening fibrosis across 3 dosing groups.
This narrative review dispels the long-held belief that reduction in salt intake leads to better health outcomes in patients with heart failure.
Many patients who took technosphere insulin saw improvements in hemoglobin A1c, but other patients saw worsening with the drug.
Antibody-drug conjugates (ADCs) revolutionize cancer therapy by delivering powerful drugs directly to tumors and minimize damage to healthy cells.
The UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Explore the definition of digiceuticals, current digiceutical products available, and pharmacy implications.
As dupilumab garners positive clinical trial results in patients with chronic obstructive pulmonary disease, it is increasingly important that pharmacists educate themselves on the treatment.
Pharmacists can play a critical role in addressing food insecurity in their communities, with a variety of tools at their disposal.
Jacqueline Bainbridge from the University of Colorado discussed what it meant to one of the recipients of the 2024 Giants of MS awards.
The test can be performed in settings that operate under the Clinical Laboratory Improvement Amendments waiver, including community pharmacies.
Pharmacists are leveraging tools, campaigns, and free samples to educate patients about medication-induced photosensitivity and the importance of sun protection.
The CATALYST trial has identified hypercortisolism as a significant factor in approximately 1.2 to 1.3 million poorly controlled diabetes patients in the United States.
Palliative care may help reduce symptoms and improve quality-of-life for patients with cardiovascular disease.
Omar Nadeem, MD, discusses positive outcomes associated with GPRC5D-targeted CAR T-cell therapy.
Validating language proficiency in bilingual pharmacists is crucial for patient safety and communication.
The results are promising for patients with relapsed or refractory follicular lymphoma and diffuse large B-cell lymphoma, and the trial is ongoing to assess the efficacy of odronextamab in other subtypes.
Donanemab-azbt is the first and only amyloid plaque targeting therapy that supports stopping therapy when the plaque is removed.
